Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Clinical trial NCT01814722 · TERMINATED

Trial details

NCT number: NCT01814722
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Study type: OBSERVATIONAL

Human Immunodeficiency Virus

Start date: 2012-11-09
Primary completion: 2013-10-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.